We report the first case, to our knowledge, of acute purulent arthritis due to Legionella pneumophila in an immunosuppressed patient. L. pneumophila was isolated from samples of blood and articular fluid cultured with use of medium specific for mycobacteria (Bactec 13A medium).
20 ϫ 10 level was 147 mg/L. A chest radiograph showed an opacity in the left lung, but there were no accompanying respiratory symptoms. Aspiration of the left knee yielded a purulent fluid with a WBC count of cells/L (90% neutrophils). Re-9 40 ϫ 10 sults of fuchsin Gram staining of the joint fluid specimen were negative.
Samples of blood and articular fluid were inoculated into 6 culture vials containing medium specific for mycobacteria (Bactec TB 13A blood culture vials; Becton Dickinson). Results were positive after 1 month of incubation, with low growth-index values of 100-150. Subcultures on buffered charcoal-yeast extract (BCYE) plates yielded 50-100 cfu of Legionella pneumophila serogroup 1. Cultures of blood and articular fluid specimens in 10 Bactec 9240 aerobic vials (Becton Dickinson Diagnostic Instrument Systems) were sterile after 30 days of incubation. L. pneumophila was isolated from a culture of articular fluid inoculated in a Bactec 13A vial; however, culture of articular fluid samples on blood agar and IsoVitaleX chocolate plates (bioMérieux) remained sterile after 4 days of incubation.
L. pneumophila serogroup 1 urinary antigen was detected by use of immunochromatographic membrane assay (Binax Now Legionella Urinary Antigen Test). In serum, the level of IgM antibodies to L. pneumophila SG1 was 300 U/mL, as determined by use of ELISA, and the IgG level was !50 U/ mL. Cultures of 3 sputum samples were negative for L. pneumophila. Culture of respiratory samples, such as bronchial aspirate or bronchoalveolar lavage fluid specimens, was not performed. The patient recovered uneventfully after 3 weeks of treatment with a combination of ofloxacin (400 mg/day) and rifampin (1.5 g/day).
Discussion. In adults with legionellosis, systemic manifestations with multiple-organ system failure are often reported [1] . In most instances, a presumptive diagnosis of extrapulmonary legionellosis is based on the clinical presentation and is confirmed retrospectively by the results of serologic studies or direct immunofluorescence testing of tissue samples. Acute purulent arthritis due to L. pneumophila has not been reported previously. Legionnaires disease, which is relatively common among immunosuppressed patients, has been described in patients with rheumatoid arthritis or systemic lupus erythematosus [2] . Cyclosporine therapy is considered a predisposing factor [2] . To our knowledge, this is the first report of a case of purulent arthritis due to L. pneumophila in which the microorganism has been isolated from articular fluid.
It was also remarkable that Legionella was isolated with use of medium specific for mycobacteria (i.e., from the Bactec TB 13A medium). Bactec 13A vials inoculated with specimens of blood and articular fluid grew L. pneumophila in 28-30 days, although cultures of these specimens in Bactec 9240 Aerobic/ F resin vials remained sterile. In addition, 3 clinical isolates of L. pneumophila were inoculated with or without blood in Bactec 
